logo
Plus   Neg
Share
Email

Johnson & Johnson To Acquire Momenta Pharmaceuticals - Quick Facts

Johnson & Johnson (JNJ) has entered into a definitive agreement to acquire Momenta Pharmaceuticals, in an all cash deal for approximately $6.5 billion. Vigor Sub, Inc., a newly formed wholly-owned subsidiary of Johnson & Johnson, will commence a tender offer to purchase all outstanding shares of Momenta for $52.50 per share. The deal will include full global rights to nipocalimab, a clinically validated anti-FcRn antibody.

"This acquisition broadens Janssen's leadership in autoimmune diseases and provides us with a major catalyst for sustained growth. Autoantibody-driven diseases are often serious, and patients are underserved by current treatment options," said Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson.

Following completion of the deal, Momenta's common stock will no longer be listed for trading on the NASDAQ Global Select Market. While the closing of the transaction is expected to be modestly dilutive, Johnson & Johnson maintained its current 2020 adjusted EPS guidance range.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health Corp. is hiring 15,000 employees across the U.S. in the fourth quarter to better equip them to tackle the anticipated rise in COVID-19 and flu incidences during the fall and winter months. This is in addition to the recruitment announced in March to fill 50,000 new full-time, part-time and temporary roles across the country in support of the company's response to the pandemic. Ireland's Data Protection Commissioner or DPC, the European Union's main data privacy regulator, is investigating Facebook over its handling of millions of children's personal data on Instagram, reports said. The agency has started two separate inquiries regarding information that email addresses and phone numbers of users under 18 were made public by the Facebook-owned app. ConocoPhillips (COP) and Concho Resources (CXO) announced Monday that they have entered into a definitive agreement to combine companies in an all-stock transaction valued at $9.7 billion. The transaction creates a company with an approximately $60 billion enterprise value and a combined resource...
Follow RTT